Global Schizophrenia Drugs Market Analysis 2019

Tutorials Get 15% Discount on First Report

The Schizophrenia Drugs market is expected to reach $10.16 billion by 2026 growing at a CAGR of 4.5% during 2018 to 2026. Schizophrenia is a serious disorder that affects how a person thinks, feels, and acts. People suffering from this disease have difficulty distinguishing between real and reel, and expressing emotions. Males are often affected with this disease. Antipsychotic drugs are generally prescribed, as they help to control symptoms like disorganized thinking, hallucinations, and delusions by blocking specific chemicals in the brain like serotonin and dopamine.

Factors such as increased demand for enhanced therapy among patients, improvement in healthcare infrastructure, and rise in R&D expenditure in the field of medicine are driving the market growth. Though, social stigma of mental health conditions restrains the market growth. Moreover, rising healthcare expenditure is the opportunity for the schizophrenia drugs market.

Based on therapeutic class, the second-generation segment is going to have a lucrative growth during the forecast period, as it is the most commonly preferred medication. Also, it is FDA approved for acute treatment of manic or mixed episodes of bipolar disorder, maintenance treatment of the bipolar disorder and irritability associated with autistic disorders.

The key vendors mentioned are Eli Lilly, Johnson & Johnson, Pfizer, Bristol-Myers Squibb, Vanda Pharma, Otsuka Pharma, Alkermes, Sumitomo Dainippon, Allergan, AstraZeneca , Titan Pharmaceutical, Alexza Pharmaceuticals, Novartis, Yoshitomi Yakuhin Corporation, Braeburn Pharmaceuticals, and Merck & Co .

Types Covered:
• Catatonic Schizophrenia
• Disorganized Schizophrenia
• Paranoid Schizophrenia
• Schizoaffective Disorder

Therapeutic Classes Covered:
• First-Generation
• Second-Generation
• Third-Generation
Treatment Types Covered:
• Antipsychotics
• Coordinated Specialty Care (CSC)
• Psychosocial Treatments
• Thioxanthenes
• Oral
• Injectables

Applications Covered:
• Unipolar Depression
• Bipolar Disorder
• Schizophrenia
• Dementia

End Users Covered:
• Hospital Pharmacies
• Clinics
• Rehabilitation Centers
• E-Commerce
• Drug Stores/Retail Pharmacies

Regions Covered:
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Key Questions Answered in this Report:
• How this market evolved since the year 2016
• Market size estimations, forecasts and CAGR for all the segments presented in the scope
• Key Market Developments and financials of the key players
• Opportunity Analysis for the new entrants
• SWOT Analysis of the key players
• Fastest growing markets analysed during the forecast period

Your Name:
Your Phone:
Company Name:
Country:
Your Email:
Description:

1 Market Synopsis

2 Research Outline
2.1 Research Snapshot
2.2 Research Methodology
2.3 Research Sources
2.3.1 Primary Research Sources
2.3.2 Secondary Research Sources

3 Market Dynamics
3.1 Drivers
3.2 Restraints

4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Schizophrenia Drugs Market, By Type
5.1 Introduction
5.2 Catatonic Schizophrenia
5.3 Disorganized Schizophrenia
5.4 Paranoid Schizophrenia
5.5 Schizoaffective Disorder

6 Global Schizophrenia Drugs Market, By Therapeutic Class
6.1 Introduction
6.2 First-Generation
6.3 Second-Generation
6.4 Third-Generation

7 Global Schizophrenia Drugs Market, By Treatment Type
7.1 Introduction
7.2 Antipsychotics
7.3 Coordinated Specialty Care (CSC)
7.4 Psychosocial Treatments
7.5 Thioxanthenes
7.6 Oral
7.7 Injectables

8 Global Schizophrenia Drugs Market, By Application
8.1 Introduction
8.2 Unipolar Depression
8.3 Bipolar Disorder
8.4 Schizophrenia
8.5 Dementia

9 Global Schizophrenia Drugs Market, By End User
9.1 Introduction
9.2 Hospital Pharmacies
9.3 Clinics
9.4 Rehabilitation Centers
9.5 E-Commerce
9.6 Drug Stores/Retail Pharmacies

10 Global Schizophrenia Drugs Market, By Geography
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 South America
10.5 Middle East & Africa

11 Strategic Benchmarking

12 Vendors Landscape
12.1 Eli Lilly
12.2 Johnson & Johnson
12.3 Pfizer
12.4 Bristol-Myers Squibb
12.5 Vanda Pharma
12.6 Otsuka Pharma
12.7 Alkermes
12.8 Sumitomo Dainippon
12.9 Allergan
12.10 AstraZeneca
12.11 Titan Pharmaceutical
12.12 Alexza Pharmaceuticals
12.13 Novartis
12.14 Yoshitomi Yakuhin Corporation
12.15 Braeburn Pharmaceuticals
12.16 Merck & Co

List of Data Tables
1 Global Schizophrenia Drugs Market Outlook, By Region (2016-2026) ($MN)
2 Global Schizophrenia Drugs Market Outlook, By Type (2016-2026) ($MN)
3 Global Schizophrenia Drugs Market Outlook, By Catatonic Schizophrenia (2016-2026) ($MN)
4 Global Schizophrenia Drugs Market Outlook, By Disorganized Schizophrenia (2016-2026) ($MN)
5 Global Schizophrenia Drugs Market Outlook, By Paranoid Schizophrenia (2016-2026) ($MN)
6 Global Schizophrenia Drugs Market Outlook, By Schizoaffective Disorder (2016-2026) ($MN)
7 Global Schizophrenia Drugs Market Outlook, By Therapeutic Class (2016-2026) ($MN)
8 Global Schizophrenia Drugs Market Outlook, By First-Generation (2016-2026) ($MN)
9 Global Schizophrenia Drugs Market Outlook, By Second-Generation (2016-2026) ($MN)
10 Global Schizophrenia Drugs Market Outlook, By Third-Generation (2016-2026) ($MN)
11 Global Schizophrenia Drugs Market Outlook, By Treatment Type (2016-2026) ($MN)
12 Global Schizophrenia Drugs Market Outlook, By Antipsychotics (2016-2026) ($MN)
13 Global Schizophrenia Drugs Market Outlook, By Coordinated Specialty Care (CSC) (2016-2026) ($MN)
14 Global Schizophrenia Drugs Market Outlook, By Psychosocial Treatments (2016-2026) ($MN)
15 Global Schizophrenia Drugs Market Outlook, By Thioxanthenes (2016-2026) ($MN)
16 Global Schizophrenia Drugs Market Outlook, By Oral (2016-2026) ($MN)
17 Global Schizophrenia Drugs Market Outlook, By Injectables (2016-2026) ($MN)
18 Global Schizophrenia Drugs Market Outlook, By Application (2016-2026) ($MN)
19 Global Schizophrenia Drugs Market Outlook, By Unipolar Depression (2016-2026) ($MN)
20 Global Schizophrenia Drugs Market Outlook, By Bipolar Disorder (2016-2026) ($MN)
21 Global Schizophrenia Drugs Market Outlook, By Schizophrenia (2016-2026) ($MN)
22 Global Schizophrenia Drugs Market Outlook, By Dementia (2016-2026) ($MN)
23 Global Schizophrenia Drugs Market Outlook, By End User (2016-2026) ($MN)
24 Global Schizophrenia Drugs Market Outlook, By Hospital Pharmacies (2016-2026) ($MN)
25 Global Schizophrenia Drugs Market Outlook, By Clinics (2016-2026) ($MN)
26 Global Schizophrenia Drugs Market Outlook, By Rehabilitation Centers (2016-2026) ($MN)
27 Global Schizophrenia Drugs Market Outlook, By E-Commerce (2016-2026) ($MN)
28 Global Schizophrenia Drugs Market Outlook, By Drug Stores/Retail Pharmacies (2016-2026) ($MN)
29 North America Schizophrenia Drugs Market Outlook, By Country (2016-2026) ($MN)
30 North America Schizophrenia Drugs Market Outlook, By Type (2016-2026) ($MN)
31 North America Schizophrenia Drugs Market Outlook, By Therapeutic Class (2016-2026) ($MN)
32 North America Schizophrenia Drugs Market Outlook, By Treatment Type (2016-2026) ($MN)
33 North America Schizophrenia Drugs Market Outlook, By Application (2016-2026) ($MN)
34 North America Schizophrenia Drugs Market Outlook, By End User (2016-2026) ($MN)
35 Europe Schizophrenia Drugs Market Outlook, By Country (2016-2026) ($MN)
36 Europe Schizophrenia Drugs Market Outlook, By Type (2016-2026) ($MN)
37 Europe Schizophrenia Drugs Market Outlook, By Therapeutic Class (2016-2026) ($MN)
38 Europe Schizophrenia Drugs Market Outlook, By Treatment Type (2016-2026) ($MN)
39 Europe Schizophrenia Drugs Market Outlook, By Application (2016-2026) ($MN)
40 Europe Schizophrenia Drugs Market Outlook, By End User (2016-2026) ($MN)
41 Asia Pacific Schizophrenia Drugs Market Outlook, By Country (2016-2026) ($MN)
42 Asia Pacific Schizophrenia Drugs Market Outlook, By Type (2016-2026) ($MN)
43 Asia Pacific Schizophrenia Drugs Market Outlook, By Therapeutic Class (2016-2026) ($MN)
44 Asia Pacific Schizophrenia Drugs Market Outlook, By Treatment Type (2016-2026) ($MN)
45 Asia Pacific Schizophrenia Drugs Market Outlook, By Application (2016-2026) ($MN)
46 Asia Pacific Schizophrenia Drugs Market Outlook, By End User (2016-2026) ($MN)
47 South America Schizophrenia Drugs Market Outlook, By Country (2016-2026) ($MN)
48 South America Schizophrenia Drugs Market Outlook, By Type (2016-2026) ($MN)
49 South America Schizophrenia Drugs Market Outlook, By Therapeutic Class (2016-2026) ($MN)
50 South America Schizophrenia Drugs Market Outlook, By Treatment Type (2016-2026) ($MN)
51 South America Schizophrenia Drugs Market Outlook, By Application (2016-2026) ($MN)
52 South America Schizophrenia Drugs Market Outlook, By End User (2016-2026) ($MN)
53 Middle East & Africa Schizophrenia Drugs Market Outlook, By Country (2016-2026) ($MN)
54 Middle East & Africa Schizophrenia Drugs Market Outlook, By Type (2016-2026) ($MN)
55 Middle East & Africa Schizophrenia Drugs Market Outlook, By Therapeutic Class (2016-2026) ($MN)
56 Middle East & Africa Schizophrenia Drugs Market Outlook, By Treatment Type (2016-2026) ($MN)
57 Middle East & Africa Schizophrenia Drugs Market Outlook, By Application (2016-2026) ($MN)
58 Middle East & Africa Schizophrenia Drugs Market Outlook, By End User (2016-2026) ($MN)

Your Name:
Your Phone:
Company Name:
Country:
Your Email:
Description:

Related Reports

Global Patient Engagement Solutions Market Analysis 2020

Dec, 2020

Patient engagement solutions allow management of the healthcare information and provide access to healthcare professionals to interact with the patients....

Global Telehealth Market Analysis 2020

Dec, 2020

Telehealth is the use of digital information and communication technologies to access advanced healthcare care and manage it accordingly and...

Global Healthcare Cloud Computing Market Analysis 2020

Dec, 2020

Cloud computing can be defined as the practice of using remote servers in place of a local server or network,...

Global Healthcare IT Integration Market Analysis 2020

Dec, 2020

Healthcare IT integration can be defined as a type of medical devices category through which the physicians and doctors can...